🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Rainbow Children's Medicare Limited RAINBOW NIFTY_SMALLNSEPHARMA

Healthcare · Medical Care Facilities · India
https://www.rainbowhospitals.in
Company Profile ↓
₹1,447.20
-5.66% 1Y
Mkt Cap₹14,706.46 Cr
P/E52.80
P/B9.59
Div. Yield0.22%
52W High₹1,598.60
52W Low₹1,101.21
Book Value₹162.18
EPS (TTM)₹27.41

Company Overview

Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 16.9%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 16.8%.

Steady Revenue Expansion

Revenue has grown at a 13.1% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 16.6%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹1,677.71 Cr (+12.2% YoY); net profit ₹278.32 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +12.2%, earnings +14.3%.
  • 5-Year Trend Long-term compounding — revenue CAGR 13.1%, profit CAGR 9.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:13.06%
1 Year:12.22%

Compounded Profit Growth

5 Years:9.70%
1 Year:14.34%

Stock Price Performance

1 Year:-5.66%
6 Months:+20.94%
3 Months:+9.34%
1 Month:-8.01%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 70% of range
₹1,101.21 ₹1,598.60
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)46.62 · Neutral
Price Performance
1M-8.01%
3M+9.34%
6M+20.94%
1Y-5.66%
Valuation vs Sector

P/E of 52.80 is above the sector median of 41.64 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 13.1% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 52.8.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
52.80
Industry PE
41.64
Forward P/E
36.58
PEG Ratio
-
Book Value
₹162.18
Price to Book
9.59
P/S
8.68
EV/EBITDA
27.79
Dividend Yield
0.22%

Growth (CAGR)

Revenue 5Y
13.06%
Profit 5Y
9.70%
Revenue (YoY)
12.22%
Earnings (YoY)
14.34%

Profitability & Returns

ROCE
16.84%
ROE
16.89%
ROA
10.03%
Profit Margin
16.59%
Op Margin
23.72%
Gross Margin
86.47%
EPS (Latest Qtr)
₹5.97
EPS (TTM)
₹27.41

Balance Sheet & Liquidity

Debt/Equity
0.54
Quick Ratio
3.33
Current Ratio
3.55
Debt
₹890.98 Cr
Total Assets
₹2,774.84 Cr
Current Assets
₹662.85 Cr
Working Capital
₹476.33 Cr

Ownership

Promoter Holding
52.59%
Chg in Prom Hold
-
FII / Inst Holding
36.42%
Chg in FII Hold
-0.09%

Financial Snapshot

Enterprise Value
₹14,706.46 Cr
Total Revenue (TTM)
₹1,677.71 Cr
EBITDA
₹586.42 Cr
Free Cash Flow
₹203.20 Cr
Operating Cash Flow
₹419.65 Cr
Shares Outstanding
₹10.16 Cr
Gross Margin
86.47%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 RAINBOW Rainbow Children's Medicare Limited NIFTY_SMALLNSEPHARMA 1,447.20 52.80 ₹14,706.46 Cr 0.22% 16.84% 16.89% 13.06% 9.70%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,899.00 39.73 ₹4.56 L Cr 0.82% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 9,100.00 94.06 ₹2.42 L Cr 0.36% 18.96% 15.32% 10.98% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,857.00 75.99 ₹1.64 L Cr 0.77% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,650.00 64.10 ₹1.24 L Cr 0.22% 19.20% 20.48% 14.85% 33.34%
6 LENSKART LENSKART SOLUTIONS LTD NIFTY_MIDNSEPHARMA 684.90 236.17 ₹1.19 L Cr 0.00% 7.21% 5.65% 35.38% 66.99%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,120.00 22.36 ₹1.13 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,385.00 28.85 ₹1.12 L Cr 0.88% 14.86% 11.27% 7.23% 11.45%
9 LAURUSLABS Laurus Labs Limited NIFTY_MIDNSEPHARMA 1,840.00 111.85 ₹99,333.61 Cr 0.13% 19.53% 16.77% 3.77% 4.00%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue 317.00 Cr287.00 Cr333.00 Cr336.00 Cr341.00 Cr330.00 Cr417.00 Cr398.00 Cr-352.93 Cr444.80 Cr445.45 Cr459.90 Cr469.99 Cr
Cost of Revenue ---------47.50 Cr62.21 Cr60.33 Cr56.98 Cr64.54 Cr
Gross Profit ---------305.43 Cr382.58 Cr385.11 Cr402.92 Cr405.44 Cr
Operating Expenses 219.00 Cr199.00 Cr215.00 Cr218.00 Cr236.00 Cr236.00 Cr270.00 Cr264.00 Cr-236.00 Cr269.56 Cr277.74 Cr299.16 Cr313.00 Cr
Operating Income 75.00 Cr63.00 Cr91.00 Cr90.00 Cr74.00 Cr60.00 Cr112.00 Cr99.00 Cr-69.44 Cr113.02 Cr107.38 Cr103.76 Cr92.45 Cr
EBITDA 98.00 Cr88.00 Cr118.00 Cr118.00 Cr106.00 Cr94.00 Cr147.00 Cr134.00 Cr-123.64 Cr157.06 Cr157.49 Cr148.23 Cr147.35 Cr
Interest Expense 14.00 Cr15.00 Cr13.00 Cr14.00 Cr17.00 Cr18.00 Cr18.00 Cr18.00 Cr-18.08 Cr18.85 Cr20.20 Cr20.50 Cr21.20 Cr
Pretax Income 70.00 Cr56.00 Cr85.00 Cr85.00 Cr69.00 Cr53.00 Cr105.00 Cr94.00 Cr-71.37 Cr102.37 Cr97.69 Cr86.79 Cr83.95 Cr
Tax Provision 16.10 Cr14.00 Cr22.10 Cr22.10 Cr17.94 Cr13.78 Cr26.25 Cr25.38 Cr-17.57 Cr26.75 Cr23.80 Cr8.57 Cr21.41 Cr
Net Income 54.00 Cr42.00 Cr63.00 Cr63.00 Cr51.00 Cr40.00 Cr79.00 Cr69.00 Cr-53.50 Cr75.25 Cr72.53 Cr77.04 Cr60.57 Cr
Diluted EPS 5.284.046.206.125.023.897.776.76-5.277.417.147.595.97

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 169.00 Cr234.00 Cr321.00 Cr402.00 Cr543.00 Cr719.00 Cr650.00 Cr-1,160.80 Cr1,285.69 Cr1,495.01 Cr1,677.71 Cr
Cost of Revenue --------158.28 Cr165.28 Cr194.92 Cr227.03 Cr
Gross Profit --------1,002.52 Cr1,120.41 Cr1,300.09 Cr1,450.68 Cr
Operating Expenses 128.00 Cr204.00 Cr266.00 Cr332.00 Cr391.00 Cr519.00 Cr485.00 Cr-687.93 Cr796.84 Cr944.09 Cr1,052.76 Cr
Operating Income 32.00 Cr12.00 Cr33.00 Cr41.00 Cr91.00 Cr132.00 Cr92.00 Cr-314.60 Cr323.57 Cr356.00 Cr397.92 Cr
EBITDA 41.00 Cr30.00 Cr55.00 Cr69.00 Cr151.00 Cr201.00 Cr165.00 Cr-426.62 Cr465.95 Cr540.90 Cr586.42 Cr
Interest Expense 3.00 Cr3.00 Cr3.00 Cr4.00 Cr42.00 Cr48.00 Cr46.00 Cr-54.57 Cr59.05 Cr72.45 Cr77.62 Cr
Pretax Income 38.00 Cr24.00 Cr41.00 Cr47.00 Cr58.00 Cr93.00 Cr56.00 Cr-281.78 Cr294.81 Cr330.00 Cr358.23 Cr
Tax Provision 13.30 Cr6.72 Cr9.84 Cr10.34 Cr12.76 Cr38.13 Cr16.24 Cr-69.40 Cr76.53 Cr85.77 Cr76.69 Cr
Net Income 25.00 Cr17.00 Cr31.00 Cr36.00 Cr45.00 Cr55.00 Cr40.00 Cr-210.83 Cr217.00 Cr243.42 Cr278.32 Cr
Diluted EPS 26.7418.2233.788.2510.1412.689.1013.6220.8921.3823.8427.41

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 231.00 Cr349.00 Cr399.00 Cr448.00 Cr926.00 Cr1,019.00 Cr1,081.00 Cr-1,770.72 Cr2,170.40 Cr2,376.99 Cr2,774.84 Cr
Current Assets --------477.88 Cr621.63 Cr822.05 Cr662.85 Cr
Cash & Equivalents --------16.96 Cr10.12 Cr20.25 Cr33.89 Cr
Inventory --------18.76 Cr23.98 Cr27.57 Cr41.63 Cr
Receivables --------62.97 Cr75.47 Cr79.39 Cr99.87 Cr
Total Liabilities --------705.81 Cr905.48 Cr901.98 Cr1,111.25 Cr
Current Liabilities --------138.87 Cr149.46 Cr150.57 Cr186.52 Cr
Long Term Debt -------27.31 Cr0---
Total Debt 22.00 Cr24.00 Cr26.00 Cr24.00 Cr476.00 Cr501.00 Cr529.00 Cr-570.32 Cr765.31 Cr763.58 Cr890.98 Cr
Total Equity 175.00 Cr284.00 Cr317.00 Cr351.00 Cr361.00 Cr394.00 Cr435.00 Cr-1,059.91 Cr1,258.93 Cr1,468.19 Cr1,648.07 Cr
Shares Outstanding --------10.15 Cr10.15 Cr10.16 Cr10.16 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 26.00 Cr17.00 Cr36.00 Cr48.00 Cr127.00 Cr170.00 Cr143.00 Cr-328.78 Cr321.40 Cr395.66 Cr419.65 Cr
Investing Cash Flow -20.00 Cr-107.00 Cr-33.00 Cr-42.00 Cr-117.00 Cr-117.00 Cr-83.00 Cr--465.20 Cr-226.47 Cr-267.80 Cr-258.65 Cr
Financing Cash Flow -7.00 Cr93.00 Cr-1.00 Cr-7.00 Cr-9.00 Cr-52.00 Cr-61.00 Cr-143.41 Cr-101.78 Cr-117.72 Cr-147.37 Cr
Capital Expenditure -61.00 Cr-63.00 Cr-57.00 Cr-151.00 Cr-85.00 Cr-74.00 Cr-76.00 Cr--141.30 Cr-353.58 Cr-145.67 Cr-216.46 Cr
Free Cash Flow -35.00 Cr-46.00 Cr-21.00 Cr-103.00 Cr42.00 Cr96.00 Cr67.00 Cr-187.49 Cr-32.17 Cr249.99 Cr203.20 Cr
Net Change in Cash -1.00 Cr3.00 Cr1.00 Cr-2.00 Cr2.00 Cr2.00 Cr-1.00 Cr-6.99 Cr-6.85 Cr10.14 Cr13.64 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------86.4%87.1%87.0%86.5%
Operating Margin % 18.9%5.1%10.3%10.2%16.8%18.4%14.2%-27.1%25.2%23.8%23.7%
Net Margin % 14.8%7.3%9.7%9.0%8.3%7.6%6.2%-18.2%16.9%16.3%16.6%
ROE % 14.3%6.0%9.8%10.3%12.5%14.0%9.2%-19.9%17.2%16.6%16.9%
ROCE % --------19.3%16.0%16.0%15.4%

Shareholding Pattern

Insiders
52.59%
Institutions
36.42%
Public Float
76.82%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for RAINBOW

Google News ue, 01 Sep 2026

A Montana drill hole cut Silver Bow Mining’s strongest section yet. The silver, gold, zinc and lead intercept lies beyond the company’s current resource estimate. - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOcTF5YWtwOTBwOHBuTFpycUJQdmFLc0lIOUtVUnZrdEU3bG1qRE9WS1Q5ZURNQTRkLURhSTI2eC1GTDdjLWkxS0dPcExpX21ROUFDMkdMWHM1b1pwT1VKSVotdW80TzRjOFVqMVpiQ3RJYVcxMDdDY3J1MWpxZjhMWk11bHdxVkhQS29xTj…

Google News Wed, 08 Apr 2026

DNR stocks rainbow trout in Mower County ahead of season opener - KTTC | Rochester, MN

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPVmloTmlsemZvZ1ktTTB5anpjTWg4V09JYjFNeUxENkVuVGlIRUZvVzVSbnE1a1FWVnJGMUYxVU9fS0paai1lcFZoQnRwUE5ESGdWLVB6S3d2Tk9GZW5pSHJ2VVV1NTZPU3hVNXU4RkRhdUpWeVdOaHItVHBYVjA0WUpJT29iSjE3cEN4c3…

Google News hu, 25 Jun 2026

RAINBOW Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9vUnIyVXI2VDhFM0l6cWc5NWxaclhwZm1mRzJ1U3d3cFJNUHNkNjJtSGhoQkZ5T2ZtX1lRdmYzMC1wX2pjcV9uYTNienFVWWVsR0p2c0RGSGpFRjJPd2NIY1VQMEZXcmhwTDFSU05jaWMyaGpaczljUlpn?oc=5" target="_blank">RAI…

Google News Mon, 06 Apr 2026

West Virginia DNR stocks gold rainbow trout statewide in annual spring tradition - WTOV

<a href="https://news.google.com/rss/articles/CBMisgJBVV95cUxQc0NMbllyVHdvdmVNU3BqNlZsSTJJSENrVktPUlV2U2VQS3o1bkhWXzhNTERTcndKZEY2V3hTSjVkOXcwVGhwU0t1TUVRMUJYVlFrTVJ2SF9kckxyNUFYd2NCSU9TUlNZT1hPcVJiOE82UWRGMzcySFBWWWZrVHlwYUVtYTVVZ0VsSzBsYz…

Google News Mon, 30 Mar 2026

IDFG to stock 214,000 rainbow trout in April — Here's where to find them - Idaho News 6

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPNUUwQ3BtTWlRTktMQ0hXU29kZnNVWnBoVjktYmhwR0JtWTB3WWdzQXdkTHQ5dU9hbWw0b25jVzhmUkgtZHBmdkEtN2ViVXJicWZNT0N6bUltbEx3V3VCSzhKc29zblVCSnM3U3ZEZ3RURWh0bDVMdExyMjFlUkE1ZlFEMURiMHJITFI0c3…

Google News ue, 05 May 2026

Rainbow Rare Earths eyeing a listing on a US stock exchange - Proactive financial news

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNNU9KZVVUT0lHQWotcm83VEU0LVYwUmE5TjN3N25fZjNjZVhXQUtkYnJwdGVXQW4tU0xRLTdUVGtMOW9paFNqc3VZLWxMODJHLWhIT3BOMUtPS19Oek1jTWtUcHgtUDY5SWNEZVBDVThSWkhVTXF6WmNHVWN3bnhnQTNkdlJzU1VYNWJiUU…

RAINBOW — Frequently Asked Questions

What is the current share price of Rainbow Children's Medicare Limited (RAINBOW)?

As of 2026-09-08 04:53 IST, Rainbow Children's Medicare Limited (RAINBOW) trades at ₹1,447.20 on NSE. Its 52-week range is ₹1,101.21 to ₹1,598.60.

What is the market capitalisation of RAINBOW?

Rainbow Children's Medicare Limited (RAINBOW) has a market capitalisation of ₹14,706.46 Cr on NSE.

What is the P/E ratio of RAINBOW?

RAINBOW trades at a trailing price-to-earnings (P/E) ratio of 52.80. The industry average P/E is 41.64. Its price-to-book (P/B) ratio is 9.59.

Does RAINBOW pay a dividend?

Rainbow Children's Medicare Limited (RAINBOW) currently offers a dividend yield of 0.22%.

What is the return on equity (ROE) of RAINBOW?

RAINBOW has a return on equity (ROE) of 16.89%. Its return on capital employed (ROCE) is 16.84%.

Is RAINBOW a good stock to buy?

This page provides a data-driven analysis of Rainbow Children's Medicare Limited (RAINBOW), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space